Swedish CDMO 3P Biopharmaceuticals inks manufacturing deal with Intervacc

27th March 2018 Uncategorised 0

3P Biopharmaceuticals, a Swedish CDMO, has inked a deal with Intervacc to produce the company’s Strangvac equine vaccine to treat strangles.

More: Swedish CDMO 3P Biopharmaceuticals inks manufacturing deal with Intervacc
Source: fierce